Hemodynamic ABI Monitor

计划入组 50 人 · 首次发布于 2024 年 12 月 10 日

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

计划入组 141 人 · 首次发布于 2024 年 7 月 9 日

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

计划入组 57 人 · 首次发布于 2017 年 6 月 29 日

ABI-6250

ABI-274

ABI-028

AMAR SEVA SANGAM

India

SEVA MINING CORP

United States

RAMAKRISHNA MISSION SEVA PRATISHTAN

India

Nykode Therapeutics Advances AI-Powered Immunotherapy Platform with Strong Clinical Progress

Avirmax Biopharma Doses First Patient in Phase I/IIa Trial of ABI-110 for Wet AMD

Assembly Biosciences Initiates Phase 1b Trial of Long-Acting HSV Helicase-Primase Inhibitor ABI-1179